加拿大 - 英文 - Health Canada

accord healthcare inc - cisplatin - solution - 1mg - cisplatin 1mg - antineoplastic agents

加拿大 - 英文 - Health Canada

sandoz canada incorporated - cisplatin - solution - 1mg - cisplatin 1mg - antineoplastic agents

加拿大 - 英文 - Health Canada

strides pharma canada inc - cisplatin - solution - 1mg - cisplatin 1mg - antineoplastic agents

加拿大 - 英文 - Health Canada

mylan pharmaceuticals ulc - cisplatin - solution - 1mg - cisplatin 1mg - antineoplastic agents

加拿大 - 英文 - Health Canada

teva canada limited - cisplatin - solution - 1.0mg - cisplatin 1.0mg - antineoplastic agents

加拿大 - 英文 - Health Canada

fresenius kabi canada ltd - cisplatin - solution - 1mg - cisplatin 1mg - antineoplastic agents

美国 - 英文 - NLM (National Library of Medicine)

wg critical care, llc - cisplatin (unii: q20q21q62j) (cisplatin - unii:q20q21q62j) - cisplatin for injection is indicated for the treatment of advanced testicular cancer. cisplatin for injection is indicated for the treatment of advanced ovarian cancer. cisplatin for injection is indicated for the treatment of advanced bladder cancer. cisplatin for injection is contraindicated in patients with severe hypersensitivity to cisplatin [see warnings and precautions (5.4)] . risk summary based on human data from published literature, cisplatin for injection can cause fetal harm when administered to pregnant women. advise pregnant women and females of reproductive potential of the potential risk to a fetus. data demonstrates transplacental transfer of cisplatin. exposure of pregnant women to cisplatin-containing chemotherapy has been associated with oligohydramnios, intrauterine growth restriction, and preterm birth. cases of neonatal acute respiratory distress syndrome, cytopenias, and hearing loss have been reported. cisplatin for injection administration to animals during and after organogenesi

加拿大 - 英文 - Health Canada

hikma canada limited - cisplatin - solution - 1mg - cisplatin 1mg

澳大利亚 - 英文 - Department of Health (Therapeutic Goods Administration)

hospira australia pty ltd - cisplatin, quantity: 1 mg/ml - injection - excipient ingredients: water for injections; sodium chloride; sodium hydroxide; mannitol - cisplatin can destroy cells in your body that may cause certain types of cancer (tumour of testis, tumour of ovary, tumour of the bladder, head and neck epithelial tumour, lung cancer and for cervical cancer in combination with radiotherapy).

爱尔兰 - 英文 - HPRA (Health Products Regulatory Authority)

hospira uk limited - cisplatin - concentrate for soln for inf - 1 mg/ml - platinum compounds